» Articles » PMID: 15516350

Mortality Analysis in Hip Fracture Patients: Implications for Design of Future Outcome Trials

Overview
Journal Br J Anaesth
Publisher Elsevier
Specialty Anesthesiology
Date 2004 Nov 2
PMID 15516350
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Patients with hip fractures are usually frail and elderly with a 30-day mortality in excess of 10% in European series. Perioperative morbidity is often multifactorial in nature, and unimodal interventions will not necessarily decrease mortality. The purpose of this prospective study was to analyse causes of mortality, and thereby the potential and limitations to decrease mortality after hip fracture surgery.

Methods: 300 consecutive, unselected hip fracture patients were treated in a multimodal rehabilitation programme with continuous perioperative epidural analgesia and anaesthesia, early surgery, standardized fluid and transfusion therapy, enforced oral nutrition and early mobilization and physiotherapy. All deaths within 30 days of surgery or during primary hospitalization were analysed and classified according to whether death was unavoidable, probably unavoidable, or potentially avoidable.

Results: Thirty-day mortality was 13.3% (40 patients) and the total perioperative mortality was 15.6% (47 patients). Death was definitely unavoidable in 28%, probably unavoidable in 15%, and in theory potentially avoidable in 57%. In the patients where death was potentially avoidable, active care was curtailed in 16 of 27 (59%) patients.

Conclusion: About a quarter of the total mortality in hip fracture patients is definitely unavoidable, and death is probably only avoidable in about half of the unselected patients. These results have important implications for the design of future outcome studies, which should focus on other relevant outcomes than mortality per se.

Citing Articles

Which performance indicators are used globally for evaluating healthcare in patients with a hip fracture? : a mixed methods systematic review.

Mazarello Paes V, Ting A, Masters J, Paes M, Tutton E, Graham S Bone Jt Open. 2025; 6(3):275-290.

PMID: 40043739 PMC: 11882308. DOI: 10.1302/2633-1462.63.BJO-2024-0104.R1.


Application of the "3-2-1" body surface localization method in intertrochanteric femoral fractures: a technical note.

Wu X, Lin Y, Xu Y, Yan L, Tu S Front Surg. 2024; 11:1394575.

PMID: 39268495 PMC: 11390651. DOI: 10.3389/fsurg.2024.1394575.


Genetic and gut microbiome determinants of SCFA circulating and fecal levels, postprandial responses and links to chronic and acute inflammation.

Nogal A, Asnicar F, Vijay A, Kouraki A, Visconti A, Louca P Gut Microbes. 2023; 15(1):2240050.

PMID: 37526398 PMC: 10395212. DOI: 10.1080/19490976.2023.2240050.


The Comparison between Cemented and Uncemented Hemiarthroplasty in Patients with Femoral Neck Fractures: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

He Y, Tang X, Liao Y, Liu S, Li L, Li P Orthop Surg. 2023; 15(7):1719-1729.

PMID: 37154088 PMC: 10350391. DOI: 10.1111/os.13716.


Risk factors of mortality and second fracture after elderly hip fracture surgery in Shanghai, China.

Chen M, Du Y, Tang W, Yu W, Li H, Zheng S J Bone Miner Metab. 2022; 40(6):951-959.

PMID: 35939235 DOI: 10.1007/s00774-022-01358-y.